Histone deacetylase inhibitor pre-treatment enhances the efficacy of DNA-interacting chemotherapeutic drugs in gastric cancer

doi:10.3748/wjg.v26.i6.598

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10385)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series, Tables (1-2) series.

Item

Count

PDF

552

WORD

190

HTML

5024

Figures (1-7)

548

Tables (1-2)

339

Sum=6653

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

462

Download

790

Sum=1252

Publishing Process of This Article

Item

Count

Browse

916

Download

1564

Sum=2480

Feb 14, 2020 (publication date) through Dec 25, 2024

Times Cited of This Article

Times Cited (17)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Feb 14, 2020; 26(6): 598-613
Published online Feb 14, 2020. doi: 10.3748/wjg.v26.i6.598

Table 1 List of primers used for carrying out real-time PCR on different genes

Gene	Forward primer, 5`-3`	Reverse primer, 5`-3`
RPS13	GCTCTCCTTTCGTTGCCTGA	ACTTCAACCAAGTGGGGACG
HDAC1	ATATCGTCTTGGCCATCCTG	TGAAGCAACCTAACCGATCC
HDAC2	GGGAATACTTTCCTGGCACA	ACGGATTGTGTAGCCACCTC
HDAC3	TGGCATTGACCCATAGCCTG	GCATATTGGTGGGGCTGACT
HDAC4	TCGCTACTGGTACGGGAAAAC	AGAGGGAAGTCATCTTTGGCG
HDAC5	ACTGTTCTCAGATGCCCAGC	TGGTGAAGAGGTGCTTGACG
HDAC6	AGTGGCCGCATTATCCTTATCC	ATCTGCGATGGACTTGGATGG
HDAC7	TTCCTGAGTGCAGGGGTAGT	CATCGCCAGGAGGTTGATGT
HDAC8	ATAACCTTGCCAACACGGCT	CTTGGCGTGATTTCCAGCAC
HDAC9	ACTGAAGCAACCAGGCAGTC	TTCACAGCCCCAACTTGTCC
HDAC10	CTGGCCTTTGAGGGGCAAAT	CAGCAGCGTCTGTACTGTCA
HDAC11	CCGGAAAATGGGGCAAAGTG	TAAGATAGCGCCTCGTGTGC
p27-CDKN1B	TTGGGGCAAAAATCCGAGGT	TGTGTTTACACAGCCCGAAGT
p21-CDKN1A	GCGACTGTGATGCGCTAATG	GAAGGTAGAGCTTGGGCAGG
p16-CDKN2A	ACTTCAGGGGTGCCACATTC	CGACCCTGTCCCTCAAATCC

Citation: Amnekar RV, Khan SA, Rashid M, Khade B, Thorat R, Gera P, Shrikhande SV, Smoot DT, Ashktorab H, Gupta S. Histone deacetylase inhibitor pre-treatment enhances the efficacy of DNA-interacting chemotherapeutic drugs in gastric cancer. World J Gastroenterol 2020; 26(6): 598-613
URL: https://www.wjgnet.com/1007-9327/full/v26/i6/598.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i6.598